BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Virobay Inc. 

1490 O’Brien Drive, Suite G
1490 O’Brien Drive, Suite G
Menlo Park  California  94025 
Phone: 1-650-833-5700 Fax: 1-650-833-6892


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Virobay Inc. Completes $8 Million Series B Preferred Stock Financing 7/16/2014 9:03:05 AM
Menlo Park's Virobay Inc. Completes $8 Million Series B Funding Round 7/16/2014 6:29:26 AM
Virobay Inc. Announces The Appointment Of James Welch As Chief Financial Officer 6/25/2014 10:27:35 AM
Virobay Inc. Appoints Thomas J. Dietz, Ph.D. To The Virobay Board Of Directors 2/25/2014 6:17:15 AM
Virobay Inc. Initiates a Phase 1 Trial of VBY-036, a Compound Intended for the Treatment of Neuropathic Pain 5/23/2013 9:53:51 AM
Virobay Inc. and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis 3/18/2013 10:12:23 AM
LEO Pharma In-Licenses Promising Compound From Virobay Inc. for Oral Treatment of Psoriasis 1/9/2012 10:55:43 AM
Virobay Inc.'s Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model 11/15/2011 5:57:40 AM